Symyx IntelliChem Delivers New and Enhanced Functionality in Intelligent ELN Platform
News Jul 18, 2005
Symyx Technologies have announced the release of the Symyx IntelliChem iELN version 5.0 suites, advancing the company's intelligent electronic lab notebook (iELN) software.
Symyx IntelliChem's electronic lab notebook software enables scientists in pharmaceutical, biotechnology, chemical and energy companies to replace paper lab notebooks while increasing productivity and data accessibility.
The version 5.0 release expands the capabilities of electronic lab notebooks by introducing new tools for parallel experimentation, advanced enterprise-level workflow, and enhanced security functionality and performance. In addition, Symyx IntelliChem has strengthened its Formulations suite, the iELN product specifically designed for pharmaceutical formulators.
"The Symyx IntelliChem iELN is unique in its ability to provide an enterprise-level single platform for global research while at the same time providing tailored user interfaces that help scientists perform daily tasks more effectively," said Paul Nowak, chief operating officer of Symyx Technologies.
"The IntelliChem iELN version 5.0 release extends these strengths across research and development: the new features and enhancements were driven by our relationships with leading companies, and we are confident that the marketplace will benefit from the results."
Analytical Tool Predicts Disease-Causing GenesNews
Predicting genes that can cause disease due to the production of truncated or altered proteins that take on a new or different function, rather than those that lose their function, is now possible thanks to an international team of researchers that has developed a new analytical tool to effectively and efficiently predict such candidate genes.
Gene Regulator May Contribute to Protein Pileup in Exfoliation GlaucomaNews
Researchers are seeking factors that contribute to protein pileup in exfoliation glaucomaREAD MORE
‘Good Cholesterol’ May Not Always be Good for Postmenopausal WomenNews
Postmenopausal factors may have an impact on the heart-protective qualities of high-density lipoproteins (HDL) – also known as ‘good cholesterol’ – according to a study led by researchers in the University of Pittsburgh Graduate School of Public Health.READ MORE